<?xml version="1.0" encoding="UTF-8"?>
<ref id="B44-molecules-25-05502">
 <label>44.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Danaei</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Dehghankhold</surname>
    <given-names>M.</given-names>
   </name>
   <name>
    <surname>Ataei</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Hasanzadeh Davarani</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Javanmard</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Dokhani</surname>
    <given-names>A.</given-names>
   </name>
   <name>
    <surname>Khorasani</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Mozafari</surname>
    <given-names>M.R.</given-names>
   </name>
  </person-group>
  <article-title>Impact of Particle Size and Polydispersity Index on the Clinical Applications of Lipidic Nanocarrier Systems</article-title>
  <source>Pharmaceutics</source>
  <year>2018</year>
  <volume>10</volume>
  <elocation-id>57</elocation-id>
  <pub-id pub-id-type="doi">10.3390/pharmaceutics10020057</pub-id>
  <?supplied-pmid 29783687?>
  <pub-id pub-id-type="pmid">29783687</pub-id>
 </element-citation>
</ref>
